[1]
“The Role of L-ornithine-L-aspartate in the Management of Minimal Hepatic Encephalopathy among Patients with Liver cirrhosis: a Systemic review and Meta-analysis ”, Acta Med Philipp, vol. 52, no. 1, Feb. 2018, doi: 10.47895/amp.v52i1.487.